IP Verse

Gene Editing In The Oocyte By Cas9 Nucleases

Patent No. EP2922393 (titled "Gene Editing In The Oocyte By Cas9 Nucleases") was filed by Helmholtz Zentrum Mnchen Deutsches Forschungszentrum FR Gesundheit UND Umwelt on Feb 27, 2014. The application was issued on Dec 28, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TACONIC BIOSCIENCESJun 3, 2020HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2922393

HELMHOLTZ ZENTRUM MNCHEN DEUTSCHES FORSCHUNGSZENTRUM FR GESUNDHEIT UND UMWELT
Application Number
EP14706855A
Filing Date
Feb 27, 2014
Status
Patent Maintained As Amended
Nov 25, 2022
Publication Date
Dec 28, 2022
External Links
Slate, Register , Google Patents